Approval · Notice of Compliance 5118 · 1995
LORABID: Notice of Compliance 5118
Issued March 23, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5118
- Date
- March 23, 1995
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form: powder for oral suspension (100mg/5ml, 200mg/5ml)
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LORABID | 02161206 | — |
| LORABID | 02161214 | — |
Medicinal ingredients
- LORACARBEF 100 MG per 5ML
- LORACARBEF 200 MG per 5ML